首页 > 最新文献

Clinical Medicine (Russian Journal)最新文献

英文 中文
Idiopathic thrombocytopenic purpura 特发性血小板减少性紫癜
Pub Date : 2024-07-23 DOI: 10.30629/0023-2149-2024-102-4-309-314
T. I. Avdeeva, A. V. Koloskov
The review presents a modern understanding of the pathophysiology and mechanisms leading to thrombocytopenia, as well as emerging treatment methods for.
这篇综述介绍了导致血小板减少的病理生理学和机制的现代认识,以及新出现的治疗方法。
{"title":"Idiopathic thrombocytopenic purpura","authors":"T. I. Avdeeva, A. V. Koloskov","doi":"10.30629/0023-2149-2024-102-4-309-314","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-4-309-314","url":null,"abstract":"The review presents a modern understanding of the pathophysiology and mechanisms leading to thrombocytopenia, as well as emerging treatment methods for.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":"133 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141811388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bloodcoagulation. Modern state 血液凝固。现代状态
Pub Date : 2024-07-23 DOI: 10.30629/0023-2149-2024-102-4-285-290
I. N. Bokarev
The article provides information on historical issues — the discovery of blood clotting factors, anticoagulant and thrombolytic therapy, on modern understanding, diagnosis and treatment of arterial and venous thrombosis, atherothrombosis, venous thromboembolism, intravascular microthrombosis syndrome, hemophilias and immunothrombosis. Assumptions about the development of atherosclerosis are presented.
文章介绍了历史问题--凝血因子的发现、抗凝剂和溶栓疗法,以及对动脉和静脉血栓形成、动脉粥样硬化血栓形成、静脉血栓栓塞症、血管内微血栓形成综合征、血友病和免疫性血栓形成的现代认识、诊断和治疗。介绍了有关动脉粥样硬化发展的假设。
{"title":"Bloodcoagulation. Modern state","authors":"I. N. Bokarev","doi":"10.30629/0023-2149-2024-102-4-285-290","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-4-285-290","url":null,"abstract":"The article provides information on historical issues — the discovery of blood clotting factors, anticoagulant and thrombolytic therapy, on modern understanding, diagnosis and treatment of arterial and venous thrombosis, atherothrombosis, venous thromboembolism, intravascular microthrombosis syndrome, hemophilias and immunothrombosis. Assumptions about the development of atherosclerosis are presented.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141813001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemorrhagic complications of emergency endovascular interventions 紧急血管内介入治疗的出血并发症
Pub Date : 2024-07-23 DOI: 10.30629/0023-2149-2024-102-4-315-322
B. S. Sukovatykh, N. V. Bolomatov, D. V. Sidorov, M. B. Sukovatykh
The article provides a systematic review of data from domestic and international literature on the issue of hemorrhagic complications that can occur during emergency endovascular interventions. It provides a generalized classifi cation of these complications and highlights the frequency of major and minor hemorrhages in diff erent locations, depending on their underlying cause. Various factors, causes, and mechanisms related to the development of hemorrhaging are discussed, including those associated with surgical access, vessel dissection, rupture, anticoagulation, anti-platelet therapy, and thrombolysis. Methods for preventing and treating these complications following endovascular procedures are also described in detail.
文章系统回顾了国内外文献中关于急诊血管内介入手术中可能出现的出血并发症的数据。文章对这些并发症进行了归纳分类,并根据其根本原因强调了不同部位大出血和小出血的频率。文中讨论了与出血发生有关的各种因素、原因和机制,包括与手术入路、血管夹层、破裂、抗凝、抗血小板治疗和溶栓有关的因素。此外,还详细介绍了血管内手术后预防和治疗这些并发症的方法。
{"title":"Hemorrhagic complications of emergency endovascular interventions","authors":"B. S. Sukovatykh, N. V. Bolomatov, D. V. Sidorov, M. B. Sukovatykh","doi":"10.30629/0023-2149-2024-102-4-315-322","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-4-315-322","url":null,"abstract":"The article provides a systematic review of data from domestic and international literature on the issue of hemorrhagic complications that can occur during emergency endovascular interventions. It provides a generalized classifi cation of these complications and highlights the frequency of major and minor hemorrhages in diff erent locations, depending on their underlying cause. Various factors, causes, and mechanisms related to the development of hemorrhaging are discussed, including those associated with surgical access, vessel dissection, rupture, anticoagulation, anti-platelet therapy, and thrombolysis. Methods for preventing and treating these complications following endovascular procedures are also described in detail.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":"77 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141812813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiome: new diagnostic and treatment options 肠道微生物组:新的诊断和治疗方案
Pub Date : 2024-07-23 DOI: 10.30629/0023-2149-2024-102-4-297-308
I. V. Mayev, S. Lyamina
The gut microbiome is of undeniable contribution to the functioning of numerous human organ systems, including higher nervous activity and behavioral reactions, and largely determines the activity of the immune system. To date, a large amount of knowledge has been accumulated about the importance of the composition, diversity and functional properties of the gut microbiota both for maintaining the human body in a state of health and for the development of pathology. Changes in the human organism are inevitably accompanied by changes in species composition and microbiome diversity. Certain patterns of changes in the human gut microbiome throughout life, as well as changes in its functional activity under the infl uence of external factors and food preferences. This research is based on search results in databases and electronic libraries PubMed (MEDLINE), Embase, Cochrane Library, Google Scholar, eLibrary in the period from 2012 to 2023. The review is devoted to the analysis of gut microbiome as a marker and predictor of chronic socially signifi cant non-communicable diseases, as well as an integral component of health gain in the context of a personalized approach of modern therapeutic strategies.  
肠道微生物群对人体许多器官系统的功能,包括高级神经活动和行为反应,有着不可否认的贡献,并在很大程度上决定着免疫系统的活动。迄今为止,人们已经积累了大量关于肠道微生物群的组成、多样性和功能特性对维持人体健康和病理发展的重要性的知识。人类机体的变化不可避免地伴随着物种组成和微生物组多样性的变化。人类肠道微生物组在一生中会发生某些模式的变化,其功能活动也会在外部因素和食物偏好的影响下发生变化。本研究基于 2012 年至 2023 年期间在 PubMed (MEDLINE)、Embase、Cochrane Library、Google Scholar、eLibrary 等数据库和电子图书馆的搜索结果。这篇综述专门分析了肠道微生物组作为慢性社会性非传染性疾病的标志物和预测因子,以及在现代治疗策略的个性化方法背景下获得健康的一个组成部分。
{"title":"Gut microbiome: new diagnostic and treatment options","authors":"I. V. Mayev, S. Lyamina","doi":"10.30629/0023-2149-2024-102-4-297-308","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-4-297-308","url":null,"abstract":"The gut microbiome is of undeniable contribution to the functioning of numerous human organ systems, including higher nervous activity and behavioral reactions, and largely determines the activity of the immune system. To date, a large amount of knowledge has been accumulated about the importance of the composition, diversity and functional properties of the gut microbiota both for maintaining the human body in a state of health and for the development of pathology. Changes in the human organism are inevitably accompanied by changes in species composition and microbiome diversity. Certain patterns of changes in the human gut microbiome throughout life, as well as changes in its functional activity under the infl uence of external factors and food preferences. This research is based on search results in databases and electronic libraries PubMed (MEDLINE), Embase, Cochrane Library, Google Scholar, eLibrary in the period from 2012 to 2023. The review is devoted to the analysis of gut microbiome as a marker and predictor of chronic socially signifi cant non-communicable diseases, as well as an integral component of health gain in the context of a personalized approach of modern therapeutic strategies.  ","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":"90 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141812594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare forms of thyrotoxicosis: thyrotropin-secreting pituitary adenomas 罕见的甲状腺毒症:分泌促甲状腺激素的垂体腺瘤
Pub Date : 2024-07-23 DOI: 10.30629/0023-2149-2024-102-4-291-296
M. A. Telegina, Zhanna Evgen'evna Belaya
Thyrotoxicosis most often occurs due to autoimmune diseases of the thyroid gland or a multi-nodular toxic goiter, but it can also be caused by TSH-secreting pituitary adenomas. In the presence of these adenomas, the levels of circulating free T3 and T4 increase in the absence of suppression, even with elevated TSH levels. Incorrect interpretation of results from studies that only measure TSH can lead to erroneous diagnoses and management strategies for patients, including unnecessary surgery or radioactive iodine therapy. This can contribute to the growth of pituitary tumors. Various tests have been used to try to diagnose them, but none have proven to be eff ective. Only laboratory tests in combination with MRI of the pituitary can accurately diagnose and prescribe treatment. When choosing a treatment for TSH-producing pituitary adenomas, preference is given to the surgical method of transsphenoidal adenomectomy. If surgery is not possible or eff ective, the method used to normalize TSH levels is to prescribe somatostatin analogs. In some cases, it is possible to use somatostatin analog therapy before neurosurgery. In exceptional circumstances, radiation therapy may be used, as with other types of adenomas.
甲亢最常见的原因是甲状腺自身免疫性疾病或多结节毒性甲状腺肿,但也可能是分泌促甲状腺激素的垂体腺瘤引起的。在这些腺瘤存在的情况下,即使促甲状腺激素水平升高,循环游离 T3 和 T4 水平也会在没有抑制的情况下升高。对仅测量促甲状腺激素的研究结果进行不正确的解释会导致错误的诊断和患者管理策略,包括不必要的手术或放射性碘治疗。这可能会导致垂体瘤的生长。已有多种检测方法被用于诊断垂体瘤,但没有一种方法被证明是有效的。只有结合脑垂体核磁共振成像进行实验室检查,才能准确诊断和治疗。在选择治疗产生促甲状腺激素的垂体腺瘤的方法时,优先考虑经蝶窦腺瘤切除术这种手术方法。如果无法进行手术或手术效果不佳,则使用体生长抑素类似物来使促甲状腺激素水平恢复正常。在某些情况下,可以在神经外科手术前使用体生长抑素类似物疗法。在特殊情况下,可以像治疗其他类型的腺瘤一样使用放射治疗。
{"title":"Rare forms of thyrotoxicosis: thyrotropin-secreting pituitary adenomas","authors":"M. A. Telegina, Zhanna Evgen'evna Belaya","doi":"10.30629/0023-2149-2024-102-4-291-296","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-4-291-296","url":null,"abstract":"Thyrotoxicosis most often occurs due to autoimmune diseases of the thyroid gland or a multi-nodular toxic goiter, but it can also be caused by TSH-secreting pituitary adenomas. In the presence of these adenomas, the levels of circulating free T3 and T4 increase in the absence of suppression, even with elevated TSH levels. Incorrect interpretation of results from studies that only measure TSH can lead to erroneous diagnoses and management strategies for patients, including unnecessary surgery or radioactive iodine therapy. This can contribute to the growth of pituitary tumors. Various tests have been used to try to diagnose them, but none have proven to be eff ective. Only laboratory tests in combination with MRI of the pituitary can accurately diagnose and prescribe treatment. When choosing a treatment for TSH-producing pituitary adenomas, preference is given to the surgical method of transsphenoidal adenomectomy. If surgery is not possible or eff ective, the method used to normalize TSH levels is to prescribe somatostatin analogs. In some cases, it is possible to use somatostatin analog therapy before neurosurgery. In exceptional circumstances, radiation therapy may be used, as with other types of adenomas.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141813013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First experience of distal hybrid surgery on lower limb arteries with port-system installation 首次在下肢动脉远端安装端口系统进行杂交手术的经验
Pub Date : 2024-05-09 DOI: 10.30629/0023-2149-2024-102-2-133-138
A. G. Vaganov, M. S. Nochnoy, D. A. Lisitsky, A. V. Gavrilenko
   Cases of occlusive lesions of the arteries of the lower leg occupy a special place in the treatment of critical lower limb ischemia. In this regard, performing open reconstructive interventions is unpromising. A new era in the treatment of occlusions of the arteries of the lower leg has become endovascular surgery. However, due to extensive occlusive lesions of the arteries of the lower leg, direct endovascular revascularization is often impossible. Currently, vascular surgeons adhere to the angiosome principle, according to which the goal of balloon angioplasty is to restore blood supply to the artery supplying the angiosome with purulent-trophic changes. In the clinical example provided, the universality of the angiosome theory is questioned, and clinical success achieved due to the discovery of collateral blood fl ow is demonstrated. The patient underwent surgery with the use of an original hybrid operation technique with the installation of a port system followed by active therapeutic-diagnostic measures on an outpatient basis for 30 days. As a result of the treatment, epithelialization of the trophic defect and cessation of critical ischemic phenomena were noted.
小腿动脉闭塞性病变在治疗严重下肢缺血中占有特殊地位。在这方面,进行开放性重建介入手术的前景并不乐观。治疗小腿动脉闭塞的新时代已经到来,这就是血管内手术。然而,由于小腿动脉闭塞病变广泛,直接进行血管内再通术往往是不可能的。目前,血管外科医生坚持血管瘤原则,根据这一原则,球囊血管成形术的目标是恢复化脓性萎缩病变血管瘤供血动脉的供血。在所提供的临床案例中,我们对血管瘤理论的普遍性提出了质疑,并展示了因发现侧支血流而取得的临床成功。患者在接受手术时使用了独创的混合手术技术,并安装了端口系统,随后在门诊采取了积极的治疗诊断措施,为期 30 天。治疗结果表明,营养缺损上皮化,临界缺血现象停止。
{"title":"First experience of distal hybrid surgery on lower limb arteries with port-system installation","authors":"A. G. Vaganov, M. S. Nochnoy, D. A. Lisitsky, A. V. Gavrilenko","doi":"10.30629/0023-2149-2024-102-2-133-138","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-2-133-138","url":null,"abstract":"   Cases of occlusive lesions of the arteries of the lower leg occupy a special place in the treatment of critical lower limb ischemia. In this regard, performing open reconstructive interventions is unpromising. A new era in the treatment of occlusions of the arteries of the lower leg has become endovascular surgery. However, due to extensive occlusive lesions of the arteries of the lower leg, direct endovascular revascularization is often impossible. Currently, vascular surgeons adhere to the angiosome principle, according to which the goal of balloon angioplasty is to restore blood supply to the artery supplying the angiosome with purulent-trophic changes. In the clinical example provided, the universality of the angiosome theory is questioned, and clinical success achieved due to the discovery of collateral blood fl ow is demonstrated. The patient underwent surgery with the use of an original hybrid operation technique with the installation of a port system followed by active therapeutic-diagnostic measures on an outpatient basis for 30 days. As a result of the treatment, epithelialization of the trophic defect and cessation of critical ischemic phenomena were noted.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":" 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of pharmacotherapy efficacy for the treatment of exacerbations of chronic obstructive pulmonary disease associated with viral infection 评估药物疗法治疗与病毒感染相关的慢性阻塞性肺病恶化的疗效
Pub Date : 2024-05-09 DOI: 10.30629/0023-2149-2024-102-2-152-162
L. A. Shpagina, O. Kotova, I. Shpagin, G. V. Kuznetsova, E. Loktin, A. Rukavitsyna, S. Karmanovskaya, L. Panacheva, E. Anikina
   Justification. Knowledge of the differences in response to therapy between phenotypes of exacerbations of chronic obstructive pulmonary disease (COPD) is necessary to improve treatment outcomes.   Objective: to determine the most effective additional pharmacological methods for virus-associated exacerbations of COPD.   Material and methods. The study included patients hospitalized with exacerbations of COPD with viral (n = 60) and viral-bacterial (n = 60) infections, and a comparison group with exacerbations of COPD with bacterial infection (n = 60). The diagnosis of COPD was based on spirometric criteria, viral infection — according to the results of PCR-RV of sputum for RNA of respiratory viruses. Treatment was carried out in real clinical practice. The groups were comparable in the use of systemic glucocorticoids, short-acting bronchodilators. Dyspnea was assessed using the TDI index (primary endpoint), lung function (spirometry, diffusion capacity for carbon monoxide), exercise tolerance (6-minute walk test), length of hospital stay (secondary endpoints). The сorrelations were determined with the use of Cox proportional hazards model.   Results. In the groups with virus-associated and viral-bacterial exacerbations, unlike bacterial exacerbations, the following types of treatment were associated with achieving TDI +1 (odds ratio — OR, 95 % confidence interval — CI): fixed triple combination (OR 2.69; 95 % CI 1.48–4.90; p = 0.010 and OR 2.74; 95 % CI 1.29–3.80; p = 0.031), inhalation of 3 % sodium chloride solution (OR 3.64; 95 % CI 1.45–5.42; p = 0.001 and OR 3.23; 95 % CI 2.15–5.43; p = 0.042), antiviral drugs (OR 2.91; 95 % CI 1.15–3.62; p = 0.009 and OR 2.76; 95 % CI 1.31–3.90; p = 0.008). As a result of treatment, an increase in DLco/Va, SpO2 after a 6-minute walk, and a decrease in the length of hospital stay were observed.   Conclusion. Detection of virus-associated infections is a promising marker for determining indications for prescribing long-acting anticholinergic drugs and beta-adrenomimetics, inhaled corticosteroids, inhalations of hypertonic sodium chloride solution, and antiviral drugs for exacerbations of COPD.
理由。有必要了解慢性阻塞性肺疾病(COPD)加重表型之间对治疗反应的差异,以改善治疗效果。 目的:确定治疗病毒相关慢性阻塞性肺疾病加重的最有效的附加药物治疗方法。 材料和方法。研究对象包括慢性阻塞性肺疾病加重期病毒感染(n = 60)和病毒细菌感染(n = 60)住院患者,以及慢性阻塞性肺疾病加重期细菌感染对比组(n = 60)。慢性阻塞性肺病的诊断依据是肺活量测定标准,病毒感染的诊断依据是痰中呼吸道病毒 RNA 的 PCR-RV 检测结果。治疗在真实的临床实践中进行。两组在使用全身性糖皮质激素和短效支气管扩张剂方面具有可比性。呼吸困难通过 TDI 指数(主要终点)、肺功能(肺活量测定、一氧化碳弥散能力)、运动耐量(6 分钟步行测试)和住院时间(次要终点)进行评估。利用考克斯比例危险模型确定了相关性。 结果显示在病毒相关性和病毒细菌性病情恶化组中,与细菌性病情恶化不同,以下治疗类型与达到 TDI +1 相关(几率比 - OR,95 % 置信区间 - CI):固定三联疗法(OR 2.69; 95 % CI 1.48-4.90; p = 0.010 和 OR 2.74; 95 % CI 1.29-3.80; p = 0.031),吸入 3 % 氯化钠溶液(OR 3.64; 95 % CI 1.45-5.42; p = 0.001 和 OR 3.23; 95 % CI 2.15-5.43;p = 0.042)、抗病毒药物(OR 2.91; 95 % CI 1.15-3.62; p = 0.009 和 OR 2.76; 95 % CI 1.31-3.90; p = 0.008)。经过治疗后,DLco/Va、6 分钟步行后的 SpO2 均有所提高,住院时间也有所缩短。 结论检测与病毒有关的感染是一个很有前景的指标,可用于确定慢性阻塞性肺疾病加重期的长效抗胆碱能药物和β-拟肾上腺素药物、吸入皮质类固醇、吸入高渗氯化钠溶液和抗病毒药物的处方适应症。
{"title":"Assessment of pharmacotherapy efficacy for the treatment of exacerbations of chronic obstructive pulmonary disease associated with viral infection","authors":"L. A. Shpagina, O. Kotova, I. Shpagin, G. V. Kuznetsova, E. Loktin, A. Rukavitsyna, S. Karmanovskaya, L. Panacheva, E. Anikina","doi":"10.30629/0023-2149-2024-102-2-152-162","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-2-152-162","url":null,"abstract":"   Justification. Knowledge of the differences in response to therapy between phenotypes of exacerbations of chronic obstructive pulmonary disease (COPD) is necessary to improve treatment outcomes.   Objective: to determine the most effective additional pharmacological methods for virus-associated exacerbations of COPD.   Material and methods. The study included patients hospitalized with exacerbations of COPD with viral (n = 60) and viral-bacterial (n = 60) infections, and a comparison group with exacerbations of COPD with bacterial infection (n = 60). The diagnosis of COPD was based on spirometric criteria, viral infection — according to the results of PCR-RV of sputum for RNA of respiratory viruses. Treatment was carried out in real clinical practice. The groups were comparable in the use of systemic glucocorticoids, short-acting bronchodilators. Dyspnea was assessed using the TDI index (primary endpoint), lung function (spirometry, diffusion capacity for carbon monoxide), exercise tolerance (6-minute walk test), length of hospital stay (secondary endpoints). The сorrelations were determined with the use of Cox proportional hazards model.   Results. In the groups with virus-associated and viral-bacterial exacerbations, unlike bacterial exacerbations, the following types of treatment were associated with achieving TDI +1 (odds ratio — OR, 95 % confidence interval — CI): fixed triple combination (OR 2.69; 95 % CI 1.48–4.90; p = 0.010 and OR 2.74; 95 % CI 1.29–3.80; p = 0.031), inhalation of 3 % sodium chloride solution (OR 3.64; 95 % CI 1.45–5.42; p = 0.001 and OR 3.23; 95 % CI 2.15–5.43; p = 0.042), antiviral drugs (OR 2.91; 95 % CI 1.15–3.62; p = 0.009 and OR 2.76; 95 % CI 1.31–3.90; p = 0.008). As a result of treatment, an increase in DLco/Va, SpO2 after a 6-minute walk, and a decrease in the length of hospital stay were observed.   Conclusion. Detection of virus-associated infections is a promising marker for determining indications for prescribing long-acting anticholinergic drugs and beta-adrenomimetics, inhaled corticosteroids, inhalations of hypertonic sodium chloride solution, and antiviral drugs for exacerbations of COPD.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":" 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamics of clinical and echocardiographic parameters of patients with cardiovascular diseases 3, 12 and 26 months after COVID-19 pneumonia COVID-19 肺炎 3、12 和 26 个月后心血管疾病患者临床和超声心动图参数的动态变化
Pub Date : 2024-05-09 DOI: 10.30629/0023-2149-2024-102-2-139-146
E. Yaroslavskaya, V. Garanina, N. Е. Shirokov, D. Krinochkin, N. A. Osokina, I. O. Korovina, A. V. Migacheva, A. D. Sapozhnikova, T. I. Petelina
   Aim: to study the dynamics of clinical and echocardiographic parameters in patients with cardiovascular diseases (CVD) at 3, 12, and 26 months after COVID-19 pneumonia.   Material and methods. The dynamics of clinical and echocardiographic parameters were studied in 130 patients with CVD at 3, 12, and 26 months after COVID-19 pneumonia (57 ± 8 years old, 46.9 % males).   Results. Between the 1st and 2nd visits, body mass index (BMI) increased (30.6 ± 5.1 kg/m2 vs. 31.4 ± 5.4 kg/m2, p < 0.001), the number of patients with obesity of grades 2 –3 increased (14.6 % vs. 23.1 %, p < 0.001). Early diastolic septal mitral annular velocity decreased from the 2nd to the 3rd visit (7.0 [6.0; 8.0] cm/s vs. 6.0 [5.0; 8.0] cm/s, p = 0.023), as did the maximum diastolic lateral tricuspid annular velocity (12.0 [11.0; 14.0] cm/s vs. 8.0 [6.0; 9.0] cm/s, p < 0.001). Between the 2nd and 3rd visits, the average global longitudinal strain of the left ventricle increased ( –19.3 ± 2.6 % vs. –19.8 ± 2.2 %, p = 0.034), the frequency of detecting its reduced values decreased (34.9 % vs. 17.4 %, p = 0.003).   Conclusion. In the long term after COVID-19 pneumonia, patients with CVD show an increase in BMI accompanied by worsening of diastolic ventricular function parameters without signifi cant progression in the frequency and severity of CVD.
目的:研究心血管疾病(CVD)患者在 COVID-19 肺炎后 3、12 和 26 个月的临床和超声心动图参数动态变化。 材料和方法对130名心血管疾病患者(57±8岁,46.9%为男性)在COVID-19肺炎后3、12和26个月的临床和超声心动图参数动态进行研究。 结果显示第1次和第2次就诊时,体重指数(BMI)上升(30.6 ± 5.1 kg/m2 vs. 31.4 ± 5.4 kg/m2,P < 0.001),2-3级肥胖患者人数增加(14.6 % vs. 23.1 %,P < 0.001)。从第2次就诊到第3次就诊,舒张早期室间隔二尖瓣瓣环速度有所下降(7.0 [6.0; 8.0] cm/s vs. 6.0 [5.0; 8.0] cm/s,p = 0.023),舒张期最大侧三尖瓣瓣环速度也有所下降(12.0 [11.0; 14.0] cm/s vs. 8.0 [6.0; 9.0] cm/s,p < 0.001)。在第 2 次和第 3 次就诊期间,左心室的平均整体纵向应变增加了(-19.3 ± 2.6 % vs. -19.8 ± 2.2 %,p = 0.034),检测到其降低值的频率降低了(34.9 % vs. 17.4 %,p = 0.003)。 结论在 COVID-19 肺炎后的长期治疗中,心血管疾病患者的体重指数会增加,同时舒张心室功能参数会恶化,但心血管疾病的发生率和严重程度不会明显增加。
{"title":"Dynamics of clinical and echocardiographic parameters of patients with cardiovascular diseases 3, 12 and 26 months after COVID-19 pneumonia","authors":"E. Yaroslavskaya, V. Garanina, N. Е. Shirokov, D. Krinochkin, N. A. Osokina, I. O. Korovina, A. V. Migacheva, A. D. Sapozhnikova, T. I. Petelina","doi":"10.30629/0023-2149-2024-102-2-139-146","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-2-139-146","url":null,"abstract":"   Aim: to study the dynamics of clinical and echocardiographic parameters in patients with cardiovascular diseases (CVD) at 3, 12, and 26 months after COVID-19 pneumonia.   Material and methods. The dynamics of clinical and echocardiographic parameters were studied in 130 patients with CVD at 3, 12, and 26 months after COVID-19 pneumonia (57 ± 8 years old, 46.9 % males).   Results. Between the 1st and 2nd visits, body mass index (BMI) increased (30.6 ± 5.1 kg/m2 vs. 31.4 ± 5.4 kg/m2, p < 0.001), the number of patients with obesity of grades 2 –3 increased (14.6 % vs. 23.1 %, p < 0.001). Early diastolic septal mitral annular velocity decreased from the 2nd to the 3rd visit (7.0 [6.0; 8.0] cm/s vs. 6.0 [5.0; 8.0] cm/s, p = 0.023), as did the maximum diastolic lateral tricuspid annular velocity (12.0 [11.0; 14.0] cm/s vs. 8.0 [6.0; 9.0] cm/s, p < 0.001). Between the 2nd and 3rd visits, the average global longitudinal strain of the left ventricle increased ( –19.3 ± 2.6 % vs. –19.8 ± 2.2 %, p = 0.034), the frequency of detecting its reduced values decreased (34.9 % vs. 17.4 %, p = 0.003).   Conclusion. In the long term after COVID-19 pneumonia, patients with CVD show an increase in BMI accompanied by worsening of diastolic ventricular function parameters without signifi cant progression in the frequency and severity of CVD.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":" 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140994877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aviation and medicine. Doctors of the aviation units of the Russian Im- perial Army in the First World War 航空与医学。第一次世界大战中俄罗斯近卫军航空部队的医生
Pub Date : 2024-05-09 DOI: 10.30629/0023-2149-2024-102-2-183-187
P. E. Krynyukov, V. G. Abashin, I. I. Velichko
   Data on the first aviation and aeronautical units of the Russian Imperial Army in the First World War are presented. Biographical information about the first air medical offi cers of these military units is given.
本文介绍了第一次世界大战中俄罗斯帝国陆军第一批航空和航空部队的数据。还提供了这些军事单位的首批航空医疗人员的履历。
{"title":"Aviation and medicine. Doctors of the aviation units of the Russian Im- perial Army in the First World War","authors":"P. E. Krynyukov, V. G. Abashin, I. I. Velichko","doi":"10.30629/0023-2149-2024-102-2-183-187","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-2-183-187","url":null,"abstract":"   Data on the first aviation and aeronautical units of the Russian Imperial Army in the First World War are presented. Biographical information about the first air medical offi cers of these military units is given.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":" 24","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140996778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical experience of using a high-intensity erbium laser for the treatment of chronic wounds 使用高强度铒激光治疗慢性伤口的临床经验
Pub Date : 2024-05-09 DOI: 10.30629/0023-2149-2024-102-2-147-151
A. E. Zaitsev, O. N. Asanov, E. Z. Sandalov, A. V. Zaitseva
   Chronic wounds are a common surgical pathology. Some types of laser radiation allow for eff ective debridement of wounds and stimulation of healing processes. High-intensity erbium laser can comprehensively aff ect tissues in all phases of the wound process, leading to accelerated healing of chronic wounds.   The aim of the study was to evaluate the eff ectiveness of using high-intensity erbium laser for treating patients with chronic wounds of various origins compared to traditional treatment.   Material and methods: An analysis of the treatment of 144 patients with chronic wounds was conducted in two groups. In the 1st group (n = 71), a high-intensity erbium laser and dressings with water-soluble ointments were used. In the 2nd group (n = 73), standard surgical treatment with similar dressings was performed. Results were evaluated using visual assessment of wound defects, planimetry, bacteriological and cytological studies, assessment of procedure tolerability, and pain intensity before and after treatment.   Results: рatients in the 1st group showed signs of healing signifi cantly earlier and more frequently achieved complete epithelialization of wounds. Laser treatment contributed to more effective decontamination of wound defects, and signs of tissue regeneration were more frequently observed in cytological images. Patients tolerated erbium laser treatment better than surgical treatment, although pain intensity after treatment did not differ between groups.   Conclusion: The study confi rmed the effectiveness of using high-intensity erbium laser for treating chronic wounds. This method can be recommended for use in surgical practice alongside other technical and pharmacological tools.
慢性伤口是一种常见的外科病理现象。某些类型的激光辐射可以有效地清除伤口并刺激愈合过程。高强度铒激光可在伤口愈合过程的各个阶段全面作用于组织,从而加速慢性伤口的愈合。 本研究旨在评估使用高强度铒激光治疗各种原因引起的慢性伤口患者的疗效,并与传统治疗方法进行比较。 材料和方法对两组 144 名慢性伤口患者的治疗情况进行了分析。第一组(71 人)使用高强度铒激光和水溶性软膏敷料。第二组(人数为 73 人)采用标准手术治疗,并使用类似的敷料。通过对伤口缺损的视觉评估、平面测量、细菌学和细胞学研究、手术耐受性评估以及治疗前后的疼痛强度来评估结果。 结果如下第一组患者的伤口愈合迹象明显更早,伤口完全上皮化的情况也更多。激光治疗能更有效地清除伤口缺损,在细胞学图像中更常观察到组织再生的迹象。与手术治疗相比,患者对铒激光治疗的耐受性更好,但治疗后的疼痛强度在组间并无差异。 结论该研究证实了使用高强度铒激光治疗慢性伤口的有效性。建议在外科实践中将这种方法与其他技术和药物工具一起使用。
{"title":"Clinical experience of using a high-intensity erbium laser for the treatment of chronic wounds","authors":"A. E. Zaitsev, O. N. Asanov, E. Z. Sandalov, A. V. Zaitseva","doi":"10.30629/0023-2149-2024-102-2-147-151","DOIUrl":"https://doi.org/10.30629/0023-2149-2024-102-2-147-151","url":null,"abstract":"   Chronic wounds are a common surgical pathology. Some types of laser radiation allow for eff ective debridement of wounds and stimulation of healing processes. High-intensity erbium laser can comprehensively aff ect tissues in all phases of the wound process, leading to accelerated healing of chronic wounds.   The aim of the study was to evaluate the eff ectiveness of using high-intensity erbium laser for treating patients with chronic wounds of various origins compared to traditional treatment.   Material and methods: An analysis of the treatment of 144 patients with chronic wounds was conducted in two groups. In the 1st group (n = 71), a high-intensity erbium laser and dressings with water-soluble ointments were used. In the 2nd group (n = 73), standard surgical treatment with similar dressings was performed. Results were evaluated using visual assessment of wound defects, planimetry, bacteriological and cytological studies, assessment of procedure tolerability, and pain intensity before and after treatment.   Results: рatients in the 1st group showed signs of healing signifi cantly earlier and more frequently achieved complete epithelialization of wounds. Laser treatment contributed to more effective decontamination of wound defects, and signs of tissue regeneration were more frequently observed in cytological images. Patients tolerated erbium laser treatment better than surgical treatment, although pain intensity after treatment did not differ between groups.   Conclusion: The study confi rmed the effectiveness of using high-intensity erbium laser for treating chronic wounds. This method can be recommended for use in surgical practice alongside other technical and pharmacological tools.","PeriodicalId":10439,"journal":{"name":"Clinical Medicine (Russian Journal)","volume":" 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140996911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Medicine (Russian Journal)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1